ORAMED PHARMACEUTICALS INC. (ORMP) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
28/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinORMP / S&P 41.47% / 15.20% |
LoseORMP / S&P ORMP unavailable / 15.00% |
LoseORMP / S&P -764.52% / 50.40% |
| 2026-Q11/3 |
WinORMP / S&P 27.97% / -4.33% |
LoseORMP / S&P ORMP unavailable / 11.30% |
LoseORMP / S&P -464.79% / 27.70% |
| 2025-Q41/3 |
WinORMP / S&P 7.95% / 2.65% |
LoseORMP / S&P ORMP unavailable / 9.00% |
LoseORMP / S&P -410.42% / 13.40% |
| 2025-Q32/3 |
WinORMP / S&P 17.33% / 8.12% |
LoseORMP / S&P ORMP unavailable / 4.61% |
WinORMP / S&P 800.00% / 13.45% |
| 2025-Q20/3 |
LoseORMP / S&P 5.14% / 10.94% |
LoseORMP / S&P ORMP unavailable / 4.83% |
LoseORMP / S&P -221.57% / 10.63% |
| 2025-Q10/3 |
LoseORMP / S&P -11.57% / -4.27% |
LoseORMP / S&P ORMP unavailable / 4.98% |
LoseORMP / S&P -373.08% / 10.57% |
| 2024-Q40/3 |
LoseORMP / S&P -0.82% / 2.41% |
LoseORMP / S&P ORMP unavailable / 5.25% |
LoseORMP / S&P -442.86% / 6.15% |
| 2024-Q30/3 |
LoseORMP / S&P -5.06% / 5.89% |
LoseORMP / S&P ORMP unavailable / 5.89% |
LoseORMP / S&P -105.95% / 6.11% |
| 2024-Q20/3 |
LoseORMP / S&P -11.99% / 4.28% |
LoseORMP / S&P ORMP unavailable / 5.38% |
LoseORMP / S&P -132.08% / 5.12% |
| 2024-Q11/3 |
WinORMP / S&P 26.41% / 10.56% |
LoseORMP / S&P ORMP unavailable / 5.71% |
LoseORMP / S&P -120.16% / 5.59% |
| 2023-Q40/3 |
LoseORMP / S&P -11.49% / 11.69% |
LoseORMP / S&P ORMP unavailable / 6.81% |
LoseORMP / S&P -114.89% / 7.78% |
| 2023-Q30/3 |
LoseORMP / S&P -27.09% / -3.27% |
LoseORMP / S&P ORMP unavailable / 7.52% |
LoseORMP / S&P ORMP unavailable / -5.03% |
| 2023-Q21/3 |
WinORMP / S&P 64.22% / 8.74% |
LoseORMP / S&P 0.26% / 9.50% |
LoseORMP / S&P ORMP unavailable / -8.57% |
| 2023-Q10/3 |
LoseORMP / S&P -81.88% / 7.50% |
LoseORMP / S&P 0.26% / 10.77% |
LoseORMP / S&P ORMP unavailable / -15.69% |
| 2022-Q41/3 |
WinORMP / S&P 85.65% / 7.56% |
LoseORMP / S&P 0.26% / 11.88% |
LoseORMP / S&P ORMP unavailable / -17.99% |
| 2022-Q31/3 |
WinORMP / S&P 41.48% / -4.88% |
LoseORMP / S&P 0.00% / 13.47% |
LoseORMP / S&P ORMP unavailable / -1.41% |
| 2022-Q20/3 |
LoseORMP / S&P -47.05% / -16.10% |
LoseORMP / S&P 0.04% / 13.71% |
LoseORMP / S&P ORMP unavailable / 11.04% |
| 2022-Q10/3 |
LoseORMP / S&P -39.43% / -4.60% |
LoseORMP / S&P -0.22% / 15.97% |
LoseORMP / S&P ORMP unavailable / 42.23% |
| 2021-Q40/3 |
LoseORMP / S&P -35.03% / 11.03% |
LoseORMP / S&P -0.52% / 15.00% |
LoseORMP / S&P ORMP unavailable / 96.40% |
| 2021-Q31/3 |
WinORMP / S&P 64.28% / 0.58% |
LoseORMP / S&P -0.52% / 10.77% |
LoseORMP / S&P ORMP unavailable / 69.42% |
| 2021-Q21/3 |
WinORMP / S&P 31.69% / 8.55% |
LoseORMP / S&P -0.55% / 6.58% |
LoseORMP / S&P ORMP unavailable / 51.81% |
| 2021-Q12/3 |
WinORMP / S&P 139.62% / 6.17% |
WinORMP / S&P -0.33% / -1.06% |
LoseORMP / S&P ORMP unavailable / 7.39% |
| 2020-Q42/3 |
WinORMP / S&P 62.45% / 12.15% |
WinORMP / S&P 0.26% / -3.72% |
LoseORMP / S&P ORMP unavailable / -33.42% |
| 2020-Q31/3 |
LoseORMP / S&P -26.06% / 8.93% |
WinORMP / S&P 0.26% / -2.04% |
LoseORMP / S&P ORMP unavailable / -27.10% |
| 2020-Q21/3 |
LoseORMP / S&P 16.12% / 20.54% |
WinORMP / S&P 2.69% / -0.46% |
LoseORMP / S&P ORMP unavailable / -27.11% |
| 2020-Q11/3 |
LoseORMP / S&P -40.97% / -19.60% |
WinORMP / S&P 5.32% / 3.47% |
LoseORMP / S&P ORMP unavailable / -14.75% |
| 2019-Q42/3 |
WinORMP / S&P 61.44% / 9.07% |
WinORMP / S&P 7.60% / 5.36% |
LoseORMP / S&P ORMP unavailable / 2.99% |
| 2019-Q31/3 |
LoseORMP / S&P -11.14% / 1.70% |
WinORMP / S&P 10.37% / 5.02% |
LoseORMP / S&P ORMP unavailable / 0.21% |
| 2019-Q21/3 |
LoseORMP / S&P -1.37% / 4.30% |
WinORMP / S&P 7.71% / 6.64% |
LoseORMP / S&P ORMP unavailable / 8.65% |
| 2019-Q11/3 |
WinORMP / S&P 21.33% / 13.65% |
LoseORMP / S&P 5.06% / 8.12% |
LoseORMP / S&P ORMP unavailable / 14.29% |
| 2018-Q40/3 |
LoseORMP / S&P -38.40% / -13.52% |
LoseORMP / S&P 2.24% / 9.05% |
LoseORMP / S&P ORMP unavailable / 18.23% |
| 2018-Q30/3 |
LoseORMP / S&P -34.45% / 7.71% |
LoseORMP / S&P -0.29% / 10.21% |
LoseORMP / S&P ORMP unavailable / 19.06% |
| 2018-Q21/3 |
WinORMP / S&P 14.13% / 3.43% |
LoseORMP / S&P -11.46% / 9.03% |
LoseORMP / S&P ORMP unavailable / 14.46% |
| 2018-Q11/3 |
LoseORMP / S&P -27.67% / -0.76% |
WinORMP / S&P 23.30% / 7.68% |
LoseORMP / S&P ORMP unavailable / 12.46% |
| 2017-Q41/3 |
LoseORMP / S&P -9.37% / 6.64% |
WinORMP / S&P 63.69% / 7.03% |
LoseORMP / S&P ORMP unavailable / 13.82% |
| 2017-Q31/3 |
WinORMP / S&P 27.80% / 4.48% |
LoseORMP / S&P ORMP unavailable / 5.68% |
LoseORMP / S&P ORMP unavailable / 17.57% |
| 2017-Q21/3 |
WinORMP / S&P 26.34% / 3.09% |
LoseORMP / S&P ORMP unavailable / 4.83% |
LoseORMP / S&P ORMP unavailable / 17.74% |
| 2017-Q10/3 |
LoseORMP / S&P 0.49% / 6.07% |
LoseORMP / S&P ORMP unavailable / 3.67% |
LoseORMP / S&P ORMP unavailable / 13.32% |
| 2016-Q40/3 |
LoseORMP / S&P -15.70% / 3.82% |
LoseORMP / S&P ORMP unavailable / 2.09% |
LoseORMP / S&P ORMP unavailable / 7.05% |
| 2016-Q30/3 |
LoseORMP / S&P -12.95% / 3.85% |
LoseORMP / S&P ORMP unavailable / 0.20% |
LoseORMP / S&P ORMP unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ORMP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 148.67% | 20.78% |
| Annualized return | 148.67% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ORMP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -72.90% | 83.14% |
| Annualized return | -22.98% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | ORMP total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -24.75% | 319.30% |
| Annualized return | -2.80% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |